Form D · Biotechnology

ABGENOMICS INTERNATIONAL INC

Los Altos, CA · CIK 0001440632

Offering snapshot reported Aug 27, 2014 · SEC filing

Reported sold
$13.2M
Offering amount: $24.5M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 13, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 27, 2014Initial$13,160,000No comparison3SEC filing
Jun 10, 2013Initial$7,950,000No comparison2SEC filing
Jun 19, 2012Amendment$16,850,000$11,400,000vs Mar 24, 201111SEC filing
Mar 24, 2011Amendment$5,450,000$2,450,000vs Apr 23, 201011SEC filing
Apr 23, 2010Initial$3,000,000No comparison9SEC filing
Jul 17, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-223665

Source: Form D, filed Aug 27, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Yung Hua Chung Director
Kim Graham Director
Chih Shan Li Executive
Rong Hwa Lim Director, Executive
Rong Hwa Lin Director, Executive
Nai Yu Pai Director
Stephen Polmar Director
Yu Chuan Yan Director
Yu Chuan Yang Director
Chia Jung Yang Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4984 El Camino Real Suite 100
Los Altos, CA, 94022